Increased plasma chemokine levels in children with Prader-Willi syndrome

American Journal of Medical Genetics, Part A

Volumn 167, Issue 3, 2015, Pages 563-571

  Butler, Merlin G ^a   Hossain, Waheeda ^a   Sulsona, Carlos ^b   Driscoll, Daniel J ^b   Manzardo, Ann M ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bioinflammatory chemokines; Children; Cytokines; Immune system; Neurodevelopment; Prader Willi syndrome

Indexed keywords

CHEMOKINE; EOTAXIN; FLT3 LIGAND; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTOXIN; MACROPHAGE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR ALPHA; CYTOKINE;

AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRADER WILLI SYNDROME; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SIBLING; BLOOD; FEMALE; GENETIC SCREENING; GENETICS; MALE; PHENOTYPE; PRADER-WILLI SYNDROME; PRESCHOOL CHILD;

CHEMOKINES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENETIC TESTING; HUMANS; MALE; PHENOTYPE; PRADER-WILLI SYNDROME; SIBLINGS;

EID: 84922979984     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36908     Document Type: Article

References (45)

1. Abdallah MW, Larsen N, Grove J, Bonefeld-Jorgensen EC, Norgaard-Pedersen B, Hougaard DM, Mortensen EL. 2013. Neonatal chemokine levels and risk of autism spectrum disorders: Findings from a Danish historic birth cohort follow-up study. Cytokine. 61:370-376.
2. Abernethy TJ, Avery OT. 1941. The occurrence during acute infections of a protein not normally present in the blood: I. distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with c polysaccharide of pneumococcus. J Exp Med 73:173-182.
3. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. 2011. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25:40-45.
4. Bozzola M, De Benedetti F, De Amici M, Jouret B, Travaglino P, Pagani S, Conte F, Tauber M. 2003. Stimulating effect of growth hormone on cytokine release in children. Eur J Endocrinol 149:397-401.
5. Butler MG, Palmer CG. 1983. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet 1:1285-1286.
6. Butler MG, Meaney FJ, Palmer CG. 1986. Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet 23:793-809.
7. Butler MG. 1990. Prader-Willi syndrome: Current understanding of cause and diagnosis. Am J Med Genet 35:319-332.
8. Butler MG, Lee PDK, Whitman BY. 2006a. Management of Prader-Willi Syndrome. 3rd ed. New York, NY: Springer-Verlag Publishers p 1-550.
9. Butler MG, Bittel DC, Kibiryeva N, Garg U. 2006b. C-reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genet Med 8:243-248.
10. Butler MG. 2011. Prader-Willi syndrome: Obesity due to genomic imprinting. Curr Genomics 12:204-215.
11. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. 2012. Prader-Willi syndrome. Genet Med 14:10-26.
12. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
13. Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, Riviello JJ, Robinson RG, Neuman RJ, Deuel RM. 2006. Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59:354-363.
14. Croonenberghs J, Bosmans E, Deboutte D, Kenis G, Maes M. 2002. Activation of the inflammatory response system in autism. Neuropsychobiology 45:1-6.
15. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. 2004. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397.
16. Daugherty BL, Siciliano SJ, DeMartino JA, Malkowitz L, Sirotina A, Springer MS. 1996. Cloning, expression, and characterization of the human eosinophil eotaxin receptor. J Experimental Med 183:2349-2354.
17. Deal CL, Tony M, Hoybye C, Allen DB, Tauber M, Christiansen JS. 2013. GrowthHormone Research Society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98:E1072-E1087.
18. Dykens EM, Lee E, Roof E. 2011. Prader-Willi syndrome and autism spectrum disorders: An evolving story. J Neurodev Disord 3:225-237.
19. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, Mirnics K, Persico AM. 2008. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis 30:303-311.
20. Hatton DD, Wheeler A, Sideris J, Sullivan K, Reichardt A, Roberts J, Clark R, Bailey DB. 2009. Developmental trajectories of young girls with fragile x syndrome. Am J Intellect Dev Disabil 114:161-171.
21. Ignatov A, Robert J, Gregory-Evans C, Schaller HC. 2006. RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein- coupled receptor 75. British J Pharmacol 149:490-497.
22. Jeay S, Sonenshein GE, Postel-Vinay MC, Kelly PA, Baixeras E. 2002. Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: New insights into signaling pathways. Mol Cell Endocrinol 188:1-7.
23. Kiess W, Gallaher B. 1998. Hormonal control of programmed cell death/apoptosis. Eur J Endocrinol 138:482-491.
24. Kooijman R, Hooghe-Peters EL, Hooghe R. 1996. Prolactin, growth hormone, and insulin-like growth factor-I in the immune system. Adv Immunol 63:377-454.
25. Maghazachi AA, Al-Aoukaty A, Schall TJ. 1996. CC chemokines induce the generation of killer cells from CD56+ cells. Euro J Immunol 26:315-319.
26. Manzardo AM, Henkhaus R, Dhillon S, Butler MG. 2012. Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int J Dev Neurosci 30:121-127.
27. Masi A, Quintana DS, Glozier N, Lloyd AR, Hickie IB, Guastella AJ. 2014. Cytokine aberrations in autism spectrum disorder: A systematic review and meta-analysis. Mol Psychiatry. 2014 Jun 17. doi: 10.1038/mp.2014.59 [Epub ahead of print].
28. Morel PA, Oriss TB. 1998. Crossregulation between Th1 and Th2 cells. Crit Rev Immunol 18:275-303.
29. Mustafa A, Nyberg F, Mustafa M, Bakhiet M, Mustafa E, Winblad B, Adem A. 1997. Growth hormone stimulates production of interferon-gamma by human peripheral mononuclear cells. Horm Res 48:11-15.
30. Najjar S, Pearlman DM. 2014. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 171:1117-1118.
31. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. 1989. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature 342:281-285.
32. Parmely MJ. 2006. USMLE Road Map: Immunology. New York, NY: Lange Medical Books/ McGraw-Hill Companies.
33. Prader A, Labhart A, Willi H. 1956. Ein syndrome von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myatonieartigem zustand im neugeborenenalter. Schweizerishe Med Wochen 86:1260-1261.
34. Reuschenbach M, Dorre J, Waterboer T, Kopitz J, Schneider M, Hoogerbrugge N, Jager E, Kloor M, Von Knebel Doeberitz M. 2014. A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens. Cancer Immunol Immunother. 63:1251-1259.
35. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM. 2005. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51:1854-1866.
36. Sodhi A, Tripathi A. 2008a. Prolactin and growth hormone induce differential cytokine and chemokine profile in murine peritoneal macrophages in vitro: Involvement of p-38 MAP kinase. STAT3 and NF-κB. Cytokine 41:162-173.
37. Sodhi A, Tripathi A. 2008b. Prolactin induced production of cytokines in macrophages involves Ca + + and p42/44 MAP kinase signaling pathway. Growth Factors 26:212-219.
38. Stuart MJ, Baune BT. 2014. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies. Neurosci Biobehav Rev 42C:93-115.
39. Tripathi A, Sodhi A. 2009. Growth hormone-induced production of cytokines in murine peritoneal macrophages in vitro: Role of JAK/STAT, PI3K, PKC and MAP kinases. Immunobiology 214:430-440.
40. Uronen-Hansson H, Allen ML, Lichtarowicz-Krynska E, Aynsley-Green A, Cole TJ, Hoiden- Guthenberg, Fryklund I, Klein L. 2003. Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood. Growth Horm IGF Res 13:282-286.
41. Valekova I, Kupcova Skalnikova H, Jarkovska K, Motlik J, Kovarova H. 2014. Multiplex immunoassays for quantification of cytokines, growth factors, and other proteins in stem cell communication. Methods Mol Biol. 2014 July 26. [Epub ahead of print].
42. Viardot A, Sze L, Purtell L, Sainsbury A, Loughnan G, Smith E, Herzog H, Steinbeck K, Campbell LV. 2010. Prader-Willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance. J Clin Endocrinol Metab 95:3392-3399.
43. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131-2135.
44. Warwick-Davies J, Lowrie DB, Cole PJ. 1995. Growth hormone is a human macrophage activating factor. Priming of human monocytes for enhanced release of H2O2. J Immunol 154:1909.
45. Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN. 2014. Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: The Early Markers for Autism (EMA) study: a case-control study. J Neuroinflammation 11:113.